We have located links that may give you full text access.
Driving forces in amyloidosis: How does a light chain make a heavy heart?
Journal of Biological Chemistry 2021 May 19
Light chain amyloidosis (AL) is a fatal disorder wherein immunoglobulin light chain misfolds and aggregates, leading to amyloid plaques in various organs. Patient-specific mutations in the antibody VL domain are tightly linked to amyloidosis, but how these mutations drive AL is unknown. In recent work, Rottenaicher et al. analyze five mutations found in the variable (VL ) domain of a cardiac AL patient. Their data suggest that decreased VL stability and increased flexibility in the core of VL , caused by mutations outside of this core, could be key to aggregation, and highlight the delicate balancing act required for antibody maturation to enable antigen recognition while not altering protein biophysics.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app